BRAF and colorectal adenocarcinoma: The PBF-fixed samples of the 25 colorectal adenocarcinomas collected in the study had been routinely subjected to Sequenom MassARRAY® to screen for KRAS/NRAS/BRAF/PIK3CA mutations.